Protein misfolding, aggregation, and conformational strains in neurodegenerative diseases

C Soto, S Pritzkow - Nature neuroscience, 2018 - nature.com
A hallmark event in neurodegenerative diseases (NDs) is the misfolding, aggregation, and
accumulation of proteins, leading to cellular dysfunction, loss of synaptic connections, and …

Medial prefrontal cortex in neurological diseases

P Xu, A Chen, Y Li, X Xing, H Lu - Physiological genomics, 2019 - journals.physiology.org
The medial prefrontal cortex (mPFC) is a crucial cortical region that integrates information
from numerous cortical and subcortical areas and converges updated information to output …

Activation of p62-Keap1-Nrf2 pathway protects 6-hydroxydopamine-induced ferroptosis in dopaminergic cells

Y Sun, L He, T Wang, W Hua, H Qin, J Wang… - Molecular …, 2020 - Springer
Parkinson's disease (PD) is a common neurodegenerative disorder primarily caused by the
death of dopaminergic neurons in the substantia nigra pars compacta (SNpc). However, the …

A timeline for Parkinson's disease

CH Hawkes, K Del Tredici, H Braak - Parkinsonism & related disorders, 2010 - Elsevier
It is reasonably well established that prior to the motor phase of classical Parkinson's
disease (PD) there is a prodromal period of several years duration. Once typical motor …

The effects of physical activity in Parkinson's disease: a review

M Lauzé, JF Daneault, C Duval - Journal of Parkinson's …, 2016 - content.iospress.com
Background: Physical activity (PA) is increasingly advocated as an adjunct intervention for
individuals with Parkinson's disease (PD). However, the specific benefits of PA on the wide …

Multi-target strategies for the improved treatment of depressive states: conceptual foundations and neuronal substrates, drug discovery and therapeutic application

MJ Millan - Pharmacology & therapeutics, 2006 - Elsevier
Major depression is a debilitating and recurrent disorder with a substantial lifetime risk and a
high social cost. Depressed patients generally display co-morbid symptoms, and depression …

Dopaminergic, serotonergic, and noradrenergic deficits in Parkinson disease

C Buddhala, SK Loftin, BM Kuley… - Annals of clinical …, 2015 - Wiley Online Library
Abstract Objective People with Parkinson disease (PD) frequently develop dementia, which
is associated with neocortical deposition of alpha‐synuclein (α‐syn) in Lewy bodies and …

Developmental origins of brain disorders: roles for dopamine

KM Money, GD Stanwood - Frontiers in cellular neuroscience, 2013 - frontiersin.org
Neurotransmitters and neuromodulators, such as dopamine, participate in a wide range of
behavioral and cognitive functions in the adult brain, including movement, cognition, and …

Metabolic brain networks associated with cognitive function in Parkinson's disease

C Huang, P Mattis, C Tang, K Perrine, M Carbon… - Neuroimage, 2007 - Elsevier
The motor manifestations of Parkinson's disease (PD) have been linked to an abnormal
spatial covariance pattern involving basal ganglia thalamocortical pathways. By contrast …

Review of the therapeutic management of Parkinson's disease. Report of a joint task force of the European Federation of Neurological Societies (EFNS) and the …

M Horstink, E Tolosa, U Bonuccelli… - European journal of …, 2006 - Wiley Online Library
To provide evidence‐based recommendations for the management of late (complicated)
Parkinson's disease (PD), based on a review of the literature. Complicated PD refers to …